etoposide has been researched along with Anaplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckwith, JB; Breslow, NE; Coccia, P; Coppes, MJ; Cotton, CA; Dome, JS; Donaldson, M; Green, DM; Grundy, PE; Haase, GM; Kalapurakal, JA; Kletzel, M; Macklis, RM; Malogolowkin, M; Perlman, EJ; Ritchey, ML; Shamberger, RC; Weetman, RM | 1 |
Brunner, KW; Cavalli, F; Hasler, E; Martin, J; Ryssel, HJ; Sonntag, RW; Tschopp, L | 1 |
2 other study(ies) available for etoposide and Anaplasia
Article | Year |
---|---|
Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
Topics: Adolescent; Anaplasia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Infant; Infant, Newborn; Kidney; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Prognosis; Prospective Studies; Radiotherapy; Rhabdoid Tumor; Sarcoma, Clear Cell; Survival Analysis; Vincristine; Wilms Tumor | 2006 |
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Topics: Adenocarcinoma; Anaplasia; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine | 1977 |